Windtree Therapeutics (WINT) News Today $0.49 -0.02 (-3.37%) (As of 12:26 PM ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Leadership Transition at Windtree Therapeutics: Fraser Retires, Latkin Takes HelmNovember 16, 2024 | msn.comWindtree Therapeutics Announces CEO Transition and Appointment of New Chief Executive OfficerNovember 15, 2024 | americanbankingnews.comWindtree Announces Leadership Transition Plan With Industry VeteransNovember 14, 2024 | markets.businessinsider.comWINT: Patient Enrollment in SEISMiC C Trial Starts, Patent Position ExpandsNovember 13, 2024 | finance.yahoo.comWindtree Therapeutics Secures Hong Kong Patent for Istaroxime in Heart Failure TreatmentNovember 6, 2024 | msn.comWindtree Announces Expansion of Patents with Issuance of Istaroxime Patent for Hong KongNovember 5, 2024 | finance.yahoo.comWindtree Therapeutics Begins SEISMiC C Trial for Advanced Cardiogenic ShockNovember 1, 2024 | msn.comWindtree Therapeutics Secures Global Patent Filings for IstaroximeOctober 25, 2024 | msn.comWindtree Therapeutics completes national phase filings for istaroximeOctober 24, 2024 | finance.yahoo.comWindtree Therapeutics Prepares to Highlight Istaroxime Progress at ThinkEquity ConferenceOctober 23, 2024 | msn.comWindtree Announces Istaroxime Cardiogenic Shock Patent Filings In Countries Around the WorldOctober 23, 2024 | globenewswire.comWindtree To Present at the ThinkEquity Conference on October 30thOctober 21, 2024 | markets.businessinsider.comWindtree Therapeutics Secures Patent for Heart Failure Treatment in JapanOctober 18, 2024 | msn.comWindtree Announces Expansion of Patents with Issuance of Istaroxime Patent for JapanOctober 17, 2024 | globenewswire.comWINT: Lead Drug Candidates, Multiple Programs, Several Upcoming Expected MilestonesOctober 14, 2024 | msn.comWindtree Announces Publication of Positive Istaroxime Phase 2b Study Trial DesignOctober 10, 2024 | finance.yahoo.comWindtree Therapeutics Publishes SEISMiC Phase 2b Trial Design for Cardiac TreatmentOctober 10, 2024 | msn.comWindtree Therapeutics Announces Recent Stock TransactionsOctober 6, 2024 | uk.investing.comWindtree reports positive heart failure drug study resultsOctober 2, 2024 | uk.investing.comWindtree Therapeutics Announces Positive Results in Heart Failure StudyOctober 2, 2024 | msn.comWindtree Therapeutics Reports Posive Topline Data From Phase 2b SEISMiC Extension StudySeptember 30, 2024 | markets.businessinsider.comWindtree Announces Positive Phase 2b Topline Clinical Results with Istaroxime Significantly Improving Cardiac Function and Blood Pressure in Heart Failure Patients in Early Cardiogenic ShockSeptember 30, 2024 | globenewswire.comWindtree Therapeutics Announces Key Investor Day for Groundbreaking Heart TreatmentSeptember 28, 2024 | msn.comWindtree Therapeutics Announces Virtual Investor Day Presentation on October 1 at 3pm ETSeptember 26, 2024 | globenewswire.comWindtree stock slides amid Phase 2b data for istaroxime for cardiogenic shockSeptember 26, 2024 | msn.comWindtree Therapeutics Announces Promising Results for Heart Failure DrugSeptember 26, 2024 | msn.comWindtree Therapeutics: Windtree Announces Positive Topline Results from Its Phase 2b SEISMiC Extension Study of Istaroxime in Early Cardiogenic ShockSeptember 26, 2024 | finanznachrichten.deWindtree Announce Positive Results From Phase 2b Study Of Istaroxime In Early Cardiogenic ShockSeptember 26, 2024 | markets.businessinsider.comWindtree Announces Positive Topline Results from Its Phase 2b SEISMiC Extension Study of Istaroxime in Early Cardiogenic ShockSeptember 25, 2024 | globenewswire.comWINDTREE THERAPEUTICS INC C/WTS (WINTW)September 15, 2024 | finance.yahoo.comWindtree Therapeutics Advances Heart Failure Treatment with SEISMiC Extension Study CompletionSeptember 6, 2024 | msn.comWhat's Going On With Windtree Therapeutics Stock Wednesday?September 5, 2024 | msn.comWindtree Completes Enrollment of Phase 2b Study of Istaroxime in Early Cardiogenic ShockSeptember 4, 2024 | stockhouse.comWindtree Therapeutics Reports Second-Quarter Financial Results and Key Business UpdatesAugust 22, 2024 | msn.comWindtree Therapeutics Reports Second Quarter 2024 Financial Results and Provides Key Business UpdatesAugust 21, 2024 | markets.businessinsider.comWindtree Therapeutics Reports Second Quarter 2024 Financial Results and Provides Key Business UpdatesAugust 20, 2024 | globenewswire.comWINT Stock Earnings: Windtree Therapeutics Reported Results for Q1 2024August 20, 2024 | investorplace.comWindtree Therapeutics Announces New Board AppointmentsAugust 16, 2024 | msn.comWindtree Announces New Additions and Changes to Its Board of DirectorsAugust 14, 2024 | markets.businessinsider.comWindtree Announces New Additions and Changes to Its Board of DirectorsAugust 14, 2024 | globenewswire.comWindtree Therapeutics Share Price (WINT.US)July 29, 2024 | lse.co.ukWhy Windtree Therapeutics (WINT) Stock Is Volatile TodayJuly 29, 2024 | msn.comWindtree Therapeutics (NASDAQ:WINT) Stock, Short Interest ReportJuly 27, 2024 | benzinga.comWhat's Going On With Windtree Therapeutics Stock?July 27, 2024 | msn.comWindtree Therapeutics Advances Heart Failure Treatment in New Clinical TrialsJuly 27, 2024 | msn.comWhy Is Windtree Therapeutics (WINT) Stock Up 116% Today?July 26, 2024 | investorplace.comWindtree Therapeutics Up 61% After Hours on Withdrawn Equity OfferingJuly 25, 2024 | marketwatch.comWindtree Therapeutics Provides Update on Istaroxime Clinical Development and Upcoming Clinical Trial DataJuly 25, 2024 | finance.yahoo.comWindtree Therapeutics Provides Update on Istaroxime Clinical Development and Upcoming Clinical Trial DataJuly 25, 2024 | globenewswire.comCash-strapped Windtree Therapeutics closes $12.9M financing dealJuly 24, 2024 | bizjournals.com Get Windtree Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for WINT and its competitors with MarketBeat's FREE daily newsletter. Email Address Blackrock’s Sending THIS Crypto Higher on Purpose (Ad)It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development… YES, I WANT THE #1 CRYPTO NOW WINT Media Mentions By Week WINT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. WINT News Sentiment▼0.000.47▲Average Medical News Sentiment WINT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. WINT Articles This Week▼31▲WINT Articles Average Week Get Windtree Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for WINT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies PKBO News Today TCBP News Today TCON News Today ALVO News Today ELOX News Today VECT News Today GRTS News Today XFOR News Today CDTX News Today AMGN News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:WINT) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Windtree Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Windtree Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
